They have very limited funds and yet you would like them to spend these very limited funds to focus on expensive trials that probably will take years and years before any meaningful results are known. Okay.

I think it makes more sense to spend limited funds on trials that will get results soon. If these results are good the share price appreciation will make it much easier to get funding for the trials you would like to see.

I expect the dilutive effect of your option to be far greater. Also if there are more funds available the trials you would like to see can be done quicker (more money for more trial sites).